Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Part of paid clinical trials in New York, New York.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT00588068
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tumor and Marrow Markers — OTHER
    Tumor and Marrow Markers

Study Details

The purpose of this study is to find out the genetic and biochemical makeup of your neuroblastic tumor, which influences its aggressiveness and the suitable therapy. These research studies include surface marker analysis, cytogenetics, cancer genes,genome sequencing, tumor growth-related genes and tumor growth in test tubes. Your blood, marrow, and hematopoietic stem cell samples will also be tested for tumors or leukemia cells, and your serum tested for anti-tumor antibodies.

Key Dates

Start date
Sep 26, 2000
Status verified
Oct 2025
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
2,070 participants (estimated)

Arms

  • Arm: 1
    Tumor and Marrow Markers

Primary Outcome Measure

To study the molecular-genetic makeup and metastasis of neuroblastic tumors. [ Time Frame: 2 years ]

Central Contacts

  • Nai-Kong Cheung, M.D., Ph.D.
    646-888-2313
  • Shakeel Modak, MD
    212-639-7623

Locations (1)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
Nai-Kong Cheung, M.D., Ph.D.
Nai-Kong Cheung, M.D., Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By condition
Neuroblastoma
By specialty
OncologyPediatric oncology
By research site
Memorial Sloan Kettering Cancer Center· New York, NY

Related Studies